Système cardiovasculaire - MedQual

29. Hood W, Dans A, Guyatt G et al. Digitalis for treatment of congestive heart failure in patients in sinus
rhythm. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD002901. DOI:
10.1002/14651858.CD002901.pub2.
30. Anonymous. Digoxine: plutôt une dose faible. La Revue Prescrire 2004;24:376-377.
31. Packer M et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med
2001;344:1651-1658.
32. Rouleau J, Roecker E, Tendera M et al. Influence of pretreatment systolic blood pressure on the effect of
carvedilol in patients with severe chronic heart failure: the Carvedilol prospective Randomzied
Cumulative Survival (COPERNICUS) study. J Am Coll Cardiol 2004;43:1423-1429.
33. Anonymous. Toevoegen van -blokkade bij matig ernstig hartfalen kan de overleving verbeteren.
Geneesmiddelenbulletin 1999;33:112-3.
34. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
35. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL
randomised intervention trial in congestive heart failure. Lancet 1999;353:2001-2007.
36. Anonymous. Bêta-bloquants dans l’insuffisance cardiaque. Folia Pharmacotherapeutica 2002;29:46-8.
www.cbip.be
37. Flather M, Shibata M, Coats A. et al. Randomized trial to determine the effect of nebivolol on mortality
and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J
2005;26:215-225.
38. Dulin B, Haas S, Abraham W et al. Do elderly systolic heart failure patients benefit from beta blockers to
the same extent as the non-elderly: a meta-analysis of >12,000 patients in large-scale clinical trials. Am J
Cardiology 2005;95:896-898.
39. Mangoni A, Jackson S. The implications of growing evidence base for drug use in elderly patients. Part
3. -adrenoceptor blockers in heart failure and thrombolytics in acute myocardial infarction. Br J Clin
Pharmacol 2006;61:513-520.
40. Salpeter S, Ormiston T, Salpeter E. et al. Cardioselective beta-blockers for chronic obstructive pulmonary
disease: a meta-analysis. Respir Med 2003;146:848-853.
41. Anonymous. Métoprolol dans l’insuffisance cardiaque réduit la mortalité, mais probablement moins que
le carvédilol. La Revue Prescrire 2003;23:810-813.
42. Prodigy. Prodigy guidance - Angina. Jan 2007. http://www.cks.library.nhs.uk/angina
43. Anonymous. L’acide acétylsalicylique dans les affections cardio-vasculaires et cérébro-vasculaires. Folia
Pharmaceutica 2002;27:73-7. www.cbip.be
44. Fox et al. European society of cardiology: Guidelines on the management of stable angina pectoris:
executive summary. Eur Heart J 2006;27:1341-1381.
45. Rutten F, Bohnen A, Schreuder B et al. NHG-Standaard. Stabiele angor pectoris. Huisarts Wet
2004;47:83-95. http://nhg.artsennet.nl
46. Snow V, Barry P, Fihn S et al. Primary care management of chronic stable angina and asymptomatic
suspected or known coronary artery disease: a clinical practice guideline from the American College of
Physicians. Ann Intern Med 2004;141:562-567.
47. SIGN. Management of stable angina. Feb 2007. www.sign.ac.uk
48. Freemantle N, Cleland J, Young P et al. Beta blockade after myocardial infarction: systematic review and
meta regression analysis. BMJ 1999;318:1730–1737.
49. Fiche de transparence. Prise en charge de l’angor stable. Mise à jour janvier 2005. www.cbip.be
50. Gibbons R, Abrams J, Chatterjee K et al. ACC/AHA 2002 Guideline Update for the Management of
Patients With Chronic Stable Angina: a report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the
Management of Patients With Chronic Stable Angina). www.acc.org
51. O’Toole L. Angina (stable). BMJ Clinical Evidence [online] 2007 [cited Dec 2007].
www.clinicalevidence.com
52. Furberg C, Psaty B, Meyer J. Nifidepine: dose-related increase in mortality in patients with coronary heart
disease. Circulation 1995;95:1326-1331.
53. Anonymous. Traitement de l’angor stable: pas d’angioplastie systématique. La Revue Prescrire
1999;19:219-20.
54. Bucher H, Hengstler P, Schindler C et al. Percutaneous transluminal coronary angioplasty versus medical
treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ
2000;321:73-7.
55. Boden W, O’Rourke R, Teo K et al. Optimal medical therapy with or without PCI for stable coronary
disease. N Engl J Med 2007;356:1503-1516.
34 Système cardiovasculaire